405 related articles for article (PubMed ID: 34721770)
1. Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Saffioti F; Mavroeidis VK
World J Gastrointest Oncol; 2021 Oct; 13(10):1336-1366. PubMed ID: 34721770
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances.
Borakati A; Froghi F; Bhogal RH; Mavroeidis VK
World J Gastroenterol; 2023 Apr; 29(13):1969-1981. PubMed ID: 37155529
[TBL] [Abstract][Full Text] [Related]
3. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
4. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
Trilianos P; Selaru F; Li Z; Gurakar A
Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
[TBL] [Abstract][Full Text] [Related]
5. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.
Ilyas SI; Eaton JE; Gores GJ
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2152-65. PubMed ID: 26051390
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.
Lee JJ; Schindera ST; Jang HJ; Fung S; Kim TK
Abdom Radiol (NY); 2017 Dec; 42(12):2898-2908. PubMed ID: 28951947
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis.
Grimsrud MM; Folseraas T
Liver Int; 2019 Dec; 39(12):2230-2237. PubMed ID: 31216595
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis (PSC): a Comprehensive Review.
Song J; Li Y; Bowlus CL; Yang G; Leung PSC; Gershwin ME
Clin Rev Allergy Immunol; 2020 Feb; 58(1):134-149. PubMed ID: 31463807
[TBL] [Abstract][Full Text] [Related]
9. The treatment of cholangiocarcinoma: a hepatologist's perspective.
Qureshi K; Jesudoss R; Al-Osaimi AM
Curr Gastroenterol Rep; 2014 Oct; 16(10):412. PubMed ID: 25183579
[TBL] [Abstract][Full Text] [Related]
10. Primary sclerosing cholangitis and cholangiocarcinoma.
Lazaridis KN; Gores GJ
Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
[TBL] [Abstract][Full Text] [Related]
11. Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma.
Lewis JT; Talwalkar JA; Rosen CB; Smyrk TC; Abraham SC
Am J Surg Pathol; 2010 Jan; 34(1):27-34. PubMed ID: 19898228
[TBL] [Abstract][Full Text] [Related]
12. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
Burak K; Angulo P; Pasha TM; Egan K; Petz J; Lindor KD
Am J Gastroenterol; 2004 Mar; 99(3):523-6. PubMed ID: 15056096
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
[TBL] [Abstract][Full Text] [Related]
14. Cholangiocarcinoma--current treatment options.
Friman S
Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
[TBL] [Abstract][Full Text] [Related]
15. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
Jesudian AB; Jacobson IM
Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
[TBL] [Abstract][Full Text] [Related]
16. Potential Role of Inflammation-Promoting Biliary Microbiome in Primary Sclerosing Cholangitis and Cholangiocarcinoma.
Miyabe K; Chandrasekhara V; Wongjarupong N; Chen J; Yang L; Johnson S; Chia N; Walther-Antonio M; Yao JZ; Harrington SC; Nordyke CK; Eaton JE; Gossard AA; Oli S; Ali HA; Lavu S; Giama NH; Hassan FA; Ali HM; Enders FT; Ilyas SI; Gores GJ; Topazian MD; Kashyap PC; Roberts LR
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565248
[TBL] [Abstract][Full Text] [Related]
17. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
18. Metal, magnet or transplant: options in primary sclerosing cholangitis with stricture.
Ahmad J
Hepatol Int; 2018 Nov; 12(6):510-519. PubMed ID: 30430358
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation in the management of perihilar cholangiocarcinoma.
Gulamhusein AF; Sanchez W
Hepat Oncol; 2015 Oct; 2(4):409-421. PubMed ID: 30191020
[TBL] [Abstract][Full Text] [Related]
20. The impact of primary sclerosing cholangitis or inflammatory bowel disease on cholangiocarcinoma phenotype, therapy, and survival.
Chahal D; Shamatutu C; Salh B; Davies J
JGH Open; 2020 Dec; 4(6):1128-1134. PubMed ID: 33319047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
